Who’s on Lown Institute’s list of most ‘socially responsible’ hospitals?
The second annual most socially responsible hospitals rankings are out from the Lown Institute. More
Johns Hopkins Bayview and University of Maryland Medical Center Midtown among most ‘socially responsible’ hospitals, according to health care think tank
Two Baltimore hospitals — Johns Hopkins Bayview Medical Center and the University of Maryland Medical Center Midtown Campus — have been ranked among the top 10 most “socially responsible” health centers in the U.S. by health care think tank and consulting organization.
More
Hospitals with top clinical outcomes often don’t score well in equity metrics, rankings find
"We think that hospitals represent really kind of probably the central part, certainly the most visible and the most active part, of all of American healthcare," Lown Institute President Vikas Saini said. "And to get a better healthcare system, hospitals absolutely have to be part of the solution." Saini noted that the individual hospitals on the honor roll were not particularly well-known names. "That was the goal of our whole exercise was to really begin to shine a spotlight on hospitals that might be doing things in a way that hadn't yet been really discovered or recognized," he said. More
Hospital Performance on Health Equity, Social Responsibility Low
Relatively few top healthcare organizations rank high for health equity and social responsibility, a jarring finding considering medicine’s statements committing to health equity over the past year, the Lown Institute reported in a press release sent to journalists. More
20 most socially responsible hospitals: Lown Institute
The Lown Institute, a nonpartisan healthcare think tank, unveiled the social responsibility ranking Sept. 21. The social responsibility list ranks 3,010 hospitals and is based on 54 metrics across three main categories: equity, value and outcomes. More
PRESS RELEASE: Equity is the missing piece for elite hospitals to be truly socially responsible
The full results of the Lown Hospitals Index reveals which hospitals achieve on equity, outcomes, and value... and which hospitals fall short. More
Should regulatory authorities approve drugs based on surrogate endpoints?
When the FDA approved new Alzheimer's drug Aduhelm based on little clinical evidence, experts protested. Yet the Aduhelm controversy is just the latest in a pattern of regulators approving new drugs based on surrogate endpoints rather than clinical outcomes that matter to patients. In The BMJ, Jeanne Lenzer and Shannon Brownlee argue that surrogate endpoints provide no guarantee of clinical benefit and should be used only as a last resort in drug trials. More
The FDA Is Broken
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients. More
How to stop hospitals suing patients
When researchers, media, and advocates teamed up to bring attention to hospital lawsuits, it led to a dramatic decrease in lawsuits filed. What can we learn from this initiative? More
After company protest, FDA agrees to review controversial drug to prevent premature birth
“This drug needs to be pulled off the market — period," said Adam Uratro, the chief of maternal-fetal medicine at MetroWest Medical Center. More
Op-ed: Hospitals need to comply with price transparency
As a matter of simple economics, hospital price transparency will improve competition and encourage more equitable pricing. More
Conflicts of Interest and Authors of Commentaries in Medical Journals
og:description Medical journals are relied on as trusted sources of medical information. For years, authors’ conflicts of interest—both disclosed and undisclosed— have repeatedly undermined the credibility of the medical profession and the medical literature. More
Health care industry sues over another transparency rule
Health care groups don't want transparency that reveals true prices. More
Hospitals that advertise aren’t necessarily better
What do hospitals that advertise their services have in common? Lown Intern Neil Trivedi explains in a guest blog post. More
National Academies’ Report Took Pharma-Friendly Stance After Millions in Gifts From Drugmakers
Congress tapped a national academies committee to examine a drug cost issue. It got a report that includes “egregious” failures to disclose conflicts of interest. More
Where Are The High-Price Hospitals? With The Transparency Rule In Effect, Colonoscopy Prices Suggest They’re All Over The Place
Although we examined only one common shoppable service in this post, the importance of identifying high-price hospitals is generalizable to a broad range of hospital services. More
Medicare has become more of a private marketplace — and it’s costly
Medicare Advantage is fundamentally altering Medicare's structure. More
Injuries Mount as Sales Reps for Device Makers Cozy Up to Surgeons, Even in Operating Rooms
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients, including former Olympian Mary Lou Retton. More
Thousands of Patients Were Implanted With Heart Pumps That the FDA Knew Could Be Dangerous
Inspectors repeatedly found manufacturing and device quality problems with the HeartWare heart pump. But the FDA did not penalize the company, and patients had the device implanted on their hearts without knowing the facts. More
Higher Prices for Cancer Surgery at National Cancer Institute–Designated Cancer Centers
The National Cancer Institute (NCI) Cancer Centers Program, developed as part of the National Cancer Act of 1971, recognizes 71 cancer centers across the US that meet rigorous standards for transdisciplinary and innovative research to develop new and better approaches to preventing, diagnosing, and treating cancer. Although this program was developed to advance cancer research, these cancer centers have an important role in translating scientific knowledge into effective treatments for patients with cancer. Moreover, these cancer centers, nearly all part of academic medical centers, attract top clinician researchers and clinician educators who seek to advance both cancer research and clinical care. More